Skip to main content

Occurrence of Kidney Stones

    Basic Details
    Date Posted
    Medical Product
    anti-diabetic agent (ADA)
    Health Outcome(s)
    kidney stone

    Modular program-based one-time assessment of prevalence and incidence of kidney stones among all members and among those with a pre-existing condition of anti-diabetic agent (ADA) use. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2004 – December 31, 2012. Modular programs are adaptable standardized programs. Results were generated using Modular Program 9, version 1.0; click here for more information. Queries were distributed in August 2013. This report includes data from 18 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    Time Period
    2004 - 2012
    Analysis Type
    Population / Cohort
    All individuals
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)